Subject Index
Coagulation Factors and Inhibitors
Fibrinolysis, fibrinogen, fibrin
Haemorrhagic Disorders
Invited
Other
Platelets
Thrombotic Disorders and antithrombotic therapy
Vascular Biology
Coagulation Factors and Inhibitors
Animal and experimental models
AT, HCII, serine protease inhibitors
Contact phase
Factor IX and vitamin K-dependent factors
Factor XIII
Factor VIII, factor V
Methods
Other coagulation factors and inhibitions
Procoagulant phospholipids
Protein C, protein S, thrombomodulin
Structural biology and drug design
Thrombin, thrombin receptors
Tissue factor, TFPI, factor VII
Antithrombin suppresses endotoxin-induced hypotension through the effect of calcitonin gene-related peptide
Isobe H., Okajima K., Uchiba M., Harada N.
Antithrombin-mediated inhibition of factor IXa by synthetic oligosaccharides
Herault J.-P., Gaich C., Bono F., Driguez P.-A., Duchaussoy P., Petitou M., Herbert J.-M
Binding of heparin to alkaline earth and transition metals
Parmar N., Paredes N., Berry L. R., Kim E., Chan A. K. C.
Characterization of the urinary metabolites of dipetarudin
Lopez M., Mende K., Nowak G.
Crystal structure at 1.7 A of aggretin, a heterodimeric C-type lectin snake venom protein
Papagrigoriou E., Nadvaev A., Clemetson K. J., Emsley J.
Crystal structure of a disintegrin from snake venom containing a cell adhesion recognition sequence RGD
Mizuno H., Fujii Y., Okuda D., Fujimoto Z., Horii K., Morita T.
Crystal structure of benzamidine-Factor VIIa/soluble tissue factor at 1.87 Å resolution: mapping of calcium, magnesium, sodium, and zinc sites in the Factor VIIa structure
Bajaj S. P., Padmanabhan K., Bajaj M. S., Liesum A., Dumas J., Prevost D., Schreuder H.
Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Lu X., Lu D., Lu X., Shang D., Morgan H., Davies J., Egglezou S., Goodwin C., Greenidge P., Scully M., Kakkar V.
Factor Xa is profoundly protected from Antithrombin–arixtra and antithrombin-Lovenox when incorporated into the prothrombinase complex
Brufatto N., Ward A., Nesheim M. E.
Function of calcium-dependent protein kinase C in platelet aggregation and thrombus formation: Studies using a chemically synthesized TAT-linked peptide blocking the C2 domain of protein kinase C-beta
Heemskerk J., Prinzen L., Feijge M. A. H., Hackeng T. M.
New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
Sofi F., Gensini F., Fatini C., Sticchi E., Attanasio M., Lenti M., Margheri M., Giglioli C., Comeglio M., Abbate R., Gensini G. F.
Structure of the Glycoprotein Ib N-terminal domain
Emsley J., Clemetson J., Clemetson K., Harrison T., Uff S.
Synthetic tripeptides with specific inhibitory action against Gp-Ib glycoprotein
Sarigiannis I., Stauropoulos G. P., Liakopoulou-Kyriakidis M., Girtovitis F., Makris P. E.
The structural role of glycine-193 in serine proteases: active site investigations of Gly193Val mutant of factor IXa and crystal structure of factor VIIa/soluble tissue factor with a reversible inhibitor
Schmidt A. E., Addison K., Schreuder H., Bajaj S. P.
Theoretical and experimental investigation of the D2194G subsitution in the C2 domain of coagulation factor V
Villoutreix B. O., Miteva M. A., Brugge J. M., Nicolaes G. A. F.
Thrombin-blood coagulation factor XIII interaction: in silico experiments
Komáromi I., Muszbek L.
Xenogenic immunoglobulins can be used in treatment coagulation disorders
Rugal V., Kravets V. N., Gonchar V. A.